C12N 2820/007
Tissue or cell-specific
Official title: tissue or cell-specific
C12N2820/007 (Tissue or cell-specific) appears on 21 US grants and 43 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 43
- Assignees
- 26
- Inventors
- 83
- Latest grant
- 2 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 3 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 1 | 3 |
| 2015 | 0 | 2 |
| 2016 | 5 | 5 |
| 2017 | 2 | 4 |
| 2018 | 4 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 3 |
| 2021 | 0 | 2 |
| 2022 | 1 | 1 |
| 2023 | 4 | 3 |
| 2024 | 2 | 2 |
| 2025 | 1 | 7 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Single-vector Type I vectors2 Sep 2025US 12,404,513 B2SNIPR Biome ApS
- Engineered phosphoenolpyruvate carboxylase enzymes17 Dec 2024US 12,168,773 B2The Regents of the University of California
- RNA-based delivery systems with levels of control2 Apr 2024US 11,946,066 B2California Institute of Technology
- Single-vector type I vectors26 Dec 2023US 11,851,663 B2SNIPR Biome ApS
- Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy11 Jul 2023US 11,697,804 B2The Johns Hopkins University
- Single-vector type i vectors22 Jan 2026US 2026/0022389 A1SNIPR Biome ApS
- Solving Brain Circuit Function and Dysfunction With Computational Modeling and Optogenetic Functional Magnetic Resonance Imaging23 Oct 2025US 2025/0325707 A1The Board of Trustees of the Leland Stanford Junior University
- Gene delivery targeting neural stem cells and neural progenitor cells23 Oct 2025US 2025/0325709 A1Rutgers, The State University of New Jersey
- Recombinant Viral Genomes and Related Compositions and Methods24 Jul 2025US 2025/0235493 A1
- Measurement of somatic l1 retrotransposition activity10 Jul 2025US 2025/0223610 A1Szegedi Biológiai Kutatóközpont
Most cited
By later US patents
- Vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells126US 9,850,499 B2Loma Linda University · 2017
- Targets for treatment of hypercholesterolemia47US 8,512,964 B2The Regents of the University of California · 2013
- Oncolytic adenoviruses for cancer treatment10US 10,016,470 B2Dnatrix, Inc. · 2018
- Single-vector type I vectors10US 11,578,333 B2SNIPR Biome ApS · 2023
- Single-vector type I vectors10US 11,629,350 B2SNIPR Biome ApS · 2023